Rapid communicationStimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol and mesulergine☆
-
Add time:09/02/2019 Source:sciencedirect.com
Using standard operant procedures with rats trained to discriminate the serotonin (5-HT) agonist 1-(-3-trifluoromethylphenyl)piperazine (TFMPP) (0.5 mg/kg) from saline, tests of stimulus generalization and stimulus antagonism were conducted with propranolol, pindolol, and mesulergine. Neither propranolol nor mesulergine antagonized the TFMPP stimulus (pindolol was not evaluated as an antagonist). However, TFMPP-stimulus generalization occurred with all three agents. These results suggest that the TFMPP-stimulus may involve both a 5-HT1B and a 5-HT1C mechanism and further suggest that propranolol, pindolol, and mesulergine may be capable of acting as agonists at certain populations of serotonin receptors.
We also recommend Trading Suppliers and Manufacturers of N-(3-Trifluoromethylphenyl)piperazine (cas 15532-75-9). Pls Click Website Link as below: cas 15532-75-9 suppliers
Prev:Original articleSynthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects
Next:Diverse metabolic pathways in the degradation of phenylalkanoic acids and their monohydroxylated derivatives in Cupriavidus sp. strain ST-14) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original articleSynthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects09/01/2019
- MDMA-like behavioral effects of N-substituted piperazines in the mouse08/31/2019
- Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazine08/30/2019
- Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment08/29/2019
- Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models08/28/2019
- Mise au pointLa 1-benzylpipérazine (BZP) et la 1-(3-trifluorométhylphényl)pipérazine (TFMPP) : émergence de deux substances donnant lieu à un usage abusif1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): Emergence of two agents which lead to misuse08/27/2019
- Development of simultaneous gas chromatography–mass spectrometric and liquid chromatography–electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine08/26/2019
- ReviewPiperazine compounds as drugs of abuse08/25/2019
- ORIGINAL ARTICLEDevelopment of a targeted GC/MS screening method and validation of an HPLC/DAD quantification method for piperazines–amphetamines mixtures in seized material08/24/2019


